Daclatasvir Dihydrochloride and Irinotecan liposome Intravenous
Determining the interaction of Daclatasvir Dihydrochloride and Irinotecan liposome Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Iron 100/C
- Daclatasvir Dihydrochloride-Iron 21/7
- Daclatasvir Dihydrochloride-Iron and Docusate
- Daclatasvir Dihydrochloride-Iron and Folic Acid
- Daclatasvir Dihydrochloride-Iron and Vitamin C
- Daclatasvir Dihydrochloride-Iron Chewable Tablets
- Irinotecan liposome Intravenous-Daclizumab
- Irinotecan liposome Intravenous-Daclizumab Subcutaneous
- Irinotecan liposome Intravenous-Dacogen
- Irinotecan liposome Intravenous-Dacomitinib
- Irinotecan liposome Intravenous-Dactinomycin
- Irinotecan liposome Intravenous-Dactinomycin Injection